Reboot Rx

?? Check out this blog post by Michelle Peng, a sophomore at the Massachusetts Institute of Technology who joined Reboot Rx this summer as a Biomedical Scientist Intern: https://lnkd.in/dQ2UJAq7. Michelle helps us validate predictions made by our AI pipeline. In her blog, Michelle reflects on her journey with Reboot Rx, sharing insights into her role in advancing generic drug repurposing and contributing to our mission of making cancer treatments more affordable through innovative research. Thank you, Michelle, for your hard work and fresh perspective! We’re grateful to have you on our team. #Cancer #DrugRepurposing #RegulatoryScience #PatientImpact #Nonprofit #Startups #SocialImpact #Innovation #Interns #RebootRx #TheSolutionMayAlreadyExist

#ScienceFridays ?? Research paper of the week ? ‘Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.’ ?? Abstract: Nonprofit organizations and other non-manufacturers have been ramping up efforts to repurpose widely available generic drugs, but they encounter many challenges to obtain regulatory approval in the U.S. The authors in this study propose how non-manufacturers could utilize existing regulatory authorities and pathways to overcome existing hurdles. ?? Authors: Devon Crittenden,?Raquel Gallagher,?Fernanda M.,?David Fox?and?Laura Kleiman, PhD. ?? Affiliation: Reboot Rx ?? Published on: Frontiers in Pharmacology (by Frontiers) Find the link to the article on our #DrugRepurposing Research Collection, curated via ScienceOpen ?? https://lnkd.in/eCFzeVqP #FutureOfMedicine #OpenScience #NetworkMedicine #PharmaInnovation

?? Big news! We are proud to announce the publication of our latest paper: “Pathways for Non-Manufacturers to Drive Generic Drug Repurposing for Cancer in the U.S.” in Frontiers in Pharmacology. In this Policy and Practice Review, we examine how new indications for generic drugs become the standard of care in oncology and discuss case studies. We offer unique insights into how the process can be accelerated to quickly bring effective and affordable cancer treatments to patients. We invite you to join the conversation on the vital role non-manufacturers like us at Reboot Rx can play in redefining the standard of care with repurposed generic drugs. A huge thank you to our dedicated team — Devon Crittenden, Raquel Gallagher, Fernanda M., David Fox, and Laura Kleiman, PhD — for their hard work and commitment to this important research. ?? Read the paper here: https://lnkd.in/e3ZMvtZM #Cancer #DrugRepurposing #RegulatoryScience #PatientImpact #Nonprofit #Startups #SocialImpact #Innovation #RebootRx #TheSolutionMayAlreadyExist

Reboot Rx is grateful to be part of the inaugural GLG Accelerates class! This program will enable us to engage diverse stakeholders to redefine the standard of care for cancer with repurposed generic drugs. As the world’s largest insight network, GLG connects leading professionals – including nearly half of the Fortune 100 – with experts who provide critical insights for informed decision-making. GLG Accelerates provides select nonprofits with one year of unlimited access to the full suite of GLG products and services. The insights from GLG’s experts will help us drive adoption of affordable and effective treatments for many cancer types. We are excited to work with the GLG team! ?? Read more: https://lnkd.in/eiXNuik #Cancer #AI #MachineLearning #Technology #DrugRepurposing #Research #PatientImpact #Nonprofit #Startups #SocialImpact #TechForGood #Innovation #RebootRx #TheSolutionMayAlreadyExist

Massachusetts is pioneering advancements in cancer research and innovation. Reboot Rx is grateful to be part of this vibrant community and receive funding from the Massachusetts Life Sciences Center. Together, we are accelerating access to life-saving therapies. ?? Read more: https://lnkd.in/eWnCZTTy #Cancer #AI #MachineLearning #Technology #DrugRepurposing #Research #PatientImpact #Nonprofit #Startups #SocialImpact #TechForGood #Innovation #RebootRx #TheSolutionMayAlreadyExist

We’re honored to be highlighted in the latest episode of the Impact Audio podcast by Shannon Farley from Fast Forward! ??? Shannon discussed how Reboot Rx has been leveraging AI since day one to surface generic drugs that cancer patients can access quickly. Our use of AI demonstrates how tech nonprofits can tackle healthcare challenges in innovative ways. The episode also offers advice for tech philanthropists, including supporting AI work with general operating support, avoiding “shiny object” funding, and taking risks for greater impact. ?? Listen here: https://lnkd.in/gxWcDmCG #cancer #AI #machinelearning #technology #drugrepurposing #research #patientimpact #nonprofit #startups #SocialImpact #TechForGood #Innovation #RebootRx #TheSolutionMayAlreadyExist

#MeetTheTeam - Meet Kristie Garza, our new Biomedical Scientist at Reboot Rx! We are excited to have her join the team. Kristie earned her PhD in Neuroscience from Emory University. Most recently, Kristie was a Senior Medical Writer at a medical communications agency, where she worked with major pharmaceutical companies to effectively communicate and market information on therapeutic drugs, primarily in oncology. “I am thrilled to join the Reboot Rx team and contribute to the goal of repurposing existing drugs to enhance patient care and quality of life. I am eager to get started and look forward to positively impacting current cancer treatment paradigms.” Learn more about Kristie at https://rebootrx.org/garza. #cancer #AI #machinelearning #technology #drugrepurposing #research #patientimpact #nonprofit #startups

#MeetTheTeam - Meet Jenny Zheng, our new Biomedical Scientist at Reboot Rx! We are thrilled to have her join the team. Jenny recently earned a Master of Public Health from Johns Hopkins University. She has experience with drug development, clinical trials, and market access analysis. “I am thrilled to join Reboot Rx and be part of its mission to enhance patient care by improving access to affordable cancer drug options. By leveraging our proprietary AI technology, we can make a true difference by identifying opportunities that can change the standard of care and pave the way for cost-effective treatments. At Reboot Rx, I believe we can make an impact and help millions of patients achieve a better quality of life.” Learn more about Jenny at https://rebootrx.org/zheng. #cancer #AI #machinelearning #technology #drugrepurposing #research #patientimpact #nonprofit #startups

#MeetTheTeam - Meet Phoebe Lee, our new Director of Portfolio & Partnerships at Reboot Rx! Phoebe will manage our drug portfolio, collaborate with cross-functional teams to prioritize and advance repurposing candidates, and build strategic partnerships to integrate these therapies into the standard of care. We are thrilled to have her join the team. Most recently, Phoebe served as Director of Business Development at Fortress Biotech, where she engaged with the rare disease community to evaluate and drive drug repurposing efforts. “I am excited to be a part of Reboot Rx and join the effort of finding creative ways to solve current challenges in the drug development ecosystem. With our AI technology, we are on our way to creating more affordable cancer therapies for patients and society while revolutionizing the landscape of drug development.” Learn more about Phoebe at https://rebootrx.org/lee. #cancer #AI #machinelearning #technology #drugrepurposing #research #patientimpact #nonprofit #startups